PTCH1: NEW TARGET FOR MONITORING CHRONIC MYELOID LEUKAEMIA AND THERAPY

被引：0
|
作者：
Cirmena, G. [1 ]
Cea, M. [1 ]
Garuti, A. [1 ]
Rocco, I. [1 ]
Palermo, C. [1 ]
Carella, A. M. [2 ]
Patrone, F. [1 ]
Ballestrero, A. [1 ]
机构：
[1] Univ Genoa, Genoa, Italy
[2] Azienda Ospedaliera Univ San Martino, Div Hematol, Genoa, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0127
引用
收藏
页码：50 / 51
页数：2
相关论文
共 50 条
  • [21] Present and future of molecular monitoring in chronic myeloid leukaemia
    Soverini, Simona
    De Benedittis, Caterina
    Mancini, Manuela
    Martinelli, Giovanni
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (03) : 337 - 349
  • [22] Different expression of hedgehog target gene PTCH1 in precancerous lesions and cancer tissues of esophagus
    Yang, Ling
    Gatalica, Zoran
    Qiu, Suimin
    Liu, Zhihua
    Bian, Yue-Hong
    Huang, Shu-Hong
    Zhang, Chi
    Weiss, Heidi
    Zhang, Hongwei
    Xie, Jingwu
    CANCER RESEARCH, 2009, 69
  • [23] HISTAMINE AND HISTAMINASE IN CHRONIC MYELOID LEUKAEMIA OF MAN .1. HISTAMINE IN THE BLOOD OF CHRONIC MYELOID LEUKAEMIA
    THIERSCH, JB
    AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1947, 25 (01): : 73 - 77
  • [24] JAK2 is a relevant target in chronic myeloid leukaemia
    Leitch, C.
    Shah, M.
    Gallipoli, P.
    Zhou, P.
    Yule, M.
    Holyoake, T. L.
    Jorgensen, H. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 77 - 77
  • [25] Pushing the limits of targeted therapy in chronic myeloid leukaemia
    Thomas O'Hare
    Matthew S. Zabriskie
    Anna M. Eiring
    Michael W. Deininger
    Nature Reviews Cancer, 2012, 12 : 513 - 526
  • [26] Pushing the limits of targeted therapy in chronic myeloid leukaemia
    O'Hare, Thomas
    Zabriskie, Matthew S.
    Eiring, Anna M.
    Deininger, Michael W.
    NATURE REVIEWS CANCER, 2012, 12 (08) : 513 - 526
  • [27] Advances in the biology and therapy of patients with chronic myeloid leukaemia
    Jabbour, Elias
    Fava, Carmen
    Kantarjian, Hagop
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (03) : 395 - 407
  • [28] Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia
    Kaeda, J
    Chase, A
    Goldman, JM
    ACTA HAEMATOLOGICA, 2002, 107 (02) : 64 - 75
  • [29] Molecular monitoring: important guide for the treatment of chronic myeloid leukaemia
    Lange, T.
    Pelz-Ackermann, O.
    Burkhardt, R.
    Niederwieser, D.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (43) : 2390 - 2394
  • [30] Facts and uncertainties in monitoring treatment response in chronic myeloid leukaemia
    Clark, Richard E.
    LEUKEMIA RESEARCH, 2009, 33 (09) : 1151 - 1155
12345